| Literature DB >> 30267958 |
Wei Li1, Yunzhan Li2, Zehua Liu1, Nattha Kerdsakundee3, Ming Zhang2, Feng Zhang1, Xueyan Liu2, Tomás Bauleth-Ramos4, Wenhua Lian2, Ermei Mäkilä5, Marianna Kemell6, Yaping Ding1, Bruno Sarmento7, Ruedeekorn Wiwattanapatapee8, Jarno Salonen5, Hongbo Zhang9, Jouni T Hirvonen1, Dongfei Liu10, Xianming Deng11, Hélder A Santos12.
Abstract
Orally administrable drug delivery vehicles are developed to manage incurable inflammatory bowel disease (IBD), however, their therapeutic outcomes are compromised by the side effects of systemic drug exposure. Herein, we use hyaluronic acid functionalized porous silicon nanoparticle to bridge enzyme-responsive hydrogel and pH-responsive polymer, generating a hierarchical structured (nano-in-nano-in-micro) vehicle with programmed properties to fully and sequentially overcome the multiple obstacles for efficiently delivering drugs locally to inflamed sites of intestine. After oral administration, the pH-responsive matrix protects the embedded hybrid nanoparticles containing drug loaded hydrogels against the spatially variable physiological environments of the gastrointestinal tract until they reach the inflamed sites of intestine, preventing premature drug release. The negatively charged hybrid nanoparticles selectively target the inflamed sites of intestine, and gradually release drug in response to the microenvironment of inflamed intestine. Overall, the developed hierarchical structured and programmed vehicles load, protect, transport and release drugs locally to inflamed sites of intestine, contributing to superior therapeutic outcomes. Such strategy could also inspire the development of numerous hierarchical structured vehicles by other porous nanoparticles and stimuli-responsive materials for the local delivery of various drugs to treat plenty of inflammatory gastrointestinal diseases, including IBD, gastrointestinal cancers and viral infections.Entities:
Keywords: Drug delivery; Hybrid nanoparticle; Porous silicon; Stimuli responsive; Targeting
Mesh:
Substances:
Year: 2018 PMID: 30267958 DOI: 10.1016/j.biomaterials.2018.09.024
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479